Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bogart GT et al. – Based on the literature reviewed here, quetiapine appears to be a safe and efficacious short–term treatment option for bipolar depression. Patients with bipolar type I showed greater improvement on the MADRS than those with bipolar type II. Patients with a rapid–cycling disease course showed an improvement in depressive symptoms, regardless of bipolar type.

Related Articles

Risk for switch from unipolar to bipolar disorder in youth with ADHD: A long term prospective controlled study
Journal of Affective Disorders, 11/13/09    Relevance Score: 70%

Understanding Bipolar Disorder; it's symptoms, effects and treatments
Internet Source, 11/05/09    Relevance Score: 70%

Epidemiology and Management of Anxiety in Patients with Bipolar Disorder
CNS Drugs, 10/30/09    Relevance Score: 70%

Bipolar Disorder Patient Care Opportunities: Let's Answer the Call
Annals of Pharmacotherapy, 10/16/09    Relevance Score: 70%

Treatment of Bipolar Disorders and Metabolic Syndrome: Implications for Primary Care
Postgraduate Medicine, 10/15/09    Relevance Score: 70%

Today in Neuro/Psych pharmacology...keeping you current

Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/04/09

Combination therapy of 17(beta)-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke
Journal of Pharmacology and Experimental Therapeutics, 12/04/09

Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: Too little juice or a miswired brain
Molecular Pharmacology, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address